Precipio Inc. (PRPO)
6.96
0.18 (2.65%)
At close: Mar 24, 2025, 3:53 PM
2.65% (1D)
| Bid | 6.13 |
| Market Cap | 10.32M |
| Revenue (ttm) | 16.82M |
| Net Income (ttm) | -3M |
| EPS (ttm) | -1.81 |
| PE Ratio (ttm) | -3.85 |
| Forward PE | 16.67 |
| Analyst | n/a |
| Ask | 9.5 |
| Volume | 4,147 |
| Avg. Volume (20D) | 9,882 |
| Open | 6.98 |
| Previous Close | 6.78 |
| Day's Range | 6.55 - 6.98 |
| 52-Week Range | 4.31 - 10.74 |
| Beta | 1.38 |
About PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the se...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 30, 2017
Employees 51
Stock Exchange NASDAQ
Ticker Symbol PRPO
Website https://www.precipiodx.com
8 months ago
+23.87%
Precipio shares are trading higher after the compa...
Unlock content with
Pro Subscription
